
Détail de l'auteur
Auteur L. LEGGIO |
Documents disponibles écrits par cet auteur (5)

![]()
Article : Périodique
R. AGABIO ; J. M. A. SINCLAIR ; G. ADDOLORATO ; H. J. AUBIN ; E. M. BERAHA ; F. CAPUTO ; J. D. CHICK ; P. DE LA SELLE ; N. FRANCHITTO ; J. C. GARBUTT ; P. S. HABER ; M. HEYDTMAN ; P. JAURY ; A. R. LINGFORD-HUGHES ; K. C. MORLEY ; C. A. MULLER ; L. OWENS ; A. PASTOR ; L. M. PATERSON ; F. PELISSIER ; B. ROLLAND ; A. STAFFORD ; A. THOMPSON ; W. VAN DEN BRINK ; R. DE BEAUREPAIRE ; L. LEGGIO |![]()
Article : Périodique
S. M. EDWARDS ; G. A. KENNA ; R. M. SWIFT ; L. LEGGIO |Harmful alcohol use is a risk factor in more than 60 diseases and injuries resulting in approximately 2.5 million deaths per year worldwide. In the United States (US) and Europe, there are only a few medications approved for alcohol dependence ([...]![]()
Article : Périodique
G. ADDOLORATO ; L. LEGGIO ; A. FERRULLI ; S. CARDONE ; G. BEDOGNI ; F. CAPUTO ; G. GASBARRINI ; R. LANDOLFI ; Baclofen Study Group |AIMS: To explore the effect of baclofen in a dose of 20 mg three times per day, compared with the already studied dose of 10 mg three times per day, in the treatment of alcohol dependence. METHODS: We present a secondary analysis of a 12-week do[...]![]()
Périodique
G. ADDOLORATO ; L. LEGGIO ; L. ABENAVOLI ; G. GASBARRINI | 2005ENGLISH : Craving plays an important role in the pathogenesis of alcohol dependence and relapse. In this review we have tried to analyse how many contrasting theories have been formulated in order to clarify the concept of craving. Many comple[...]![]()
Article : Périodique
R. DE BEAUREPAIRE ; J. M. A. SINCLAIR ; M. HEYDTMANN ; G. ADDOLORATO ; H. J. AUBIN ; E. M. BERAHA ; F. CAPUTO ; J. D. CHICK ; P. DE LA SELLE ; N. FRANCHITTO ; J. C. GARBUTT ; P. S. HABER ; P. JAURY ; A. R. LINGFORD-HUGHES ; K. C. MORLEY ; C. A. MULLER ; L. OWENS ; A. PASTOR ; L. M. PATERSON ; F. PELISSIER ; B. ROLLAND ; A. STAFFORD ; A. THOMPSON ; W. VAN DEN BRINK ; L. LEGGIO ; R. AGABIO |Alcohol use disorder (AUD) is a brain disorder associated with high rates of mortality and morbidity worldwide. Baclofen, a selective gamma-aminobutyric acid-B (GABA-B) receptor agonist, has emerged as a promising drug for AUD. The use of this d[...]